Literature DB >> 22465493

Management of snakebites in France.

Luc de Haro1.   

Abstract

Although not a major health problem in Europe, snakebite in the old continent was the focus of recent studies to evaluate their overall incidence and define management techniques. The purpose of this three-part report is to present the experience of the Marseille Poison Centre with snakebite in France. The first section deals with viper envenomation that now benefits from a validated therapeutic protocol using of purified antivenom of proven efficacy and tolerance in patients showing grade 2 and 3 symptoms. The second section describes the highly variable snakebite situation in French overseas territories that include areas where local species require specialized management, e.g. Martinique and French Guiana. The third section involves the emerging problems associated with the keeping of exotic snakes as pets with problems related to the use of antivenoms from foreign countries. The exotic-snake pets fashion was at the origin of the creation of a national antivenom bank by two French poison centers (Angers and Marseille) to ensure prompt delivery of antivenoms for exotic snake envenomation anywhere in mainland France.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22465493     DOI: 10.1016/j.toxicon.2012.03.013

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  7 in total

1.  Non-native (exotic) snake envenomations in the U.S., 2005-2011.

Authors:  Brandon J Warrick; Leslie V Boyer; Steven A Seifert
Journal:  Toxins (Basel)       Date:  2014-09-29       Impact factor: 4.546

Review 2.  Bilateral Pulmonary Embolism Following a Viper Envenomation in France: A Case Report and Review.

Authors:  Géraldine Bart; Samuel Pineau; Charlotte Biron; Jérôme Connault; Mathieu Artifoni
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

3.  Variability in venom composition of European viper subspecies limits the cross-effectiveness of antivenoms.

Authors:  Giulia Zanetti; Elisa Duregotti; Carlo Alessandro Locatelli; Andrea Giampreti; Davide Lonati; Ornella Rossetto; Marco Pirazzini
Journal:  Sci Rep       Date:  2018-06-29       Impact factor: 4.379

4.  Neurotoxicity and Other Clinical Manifestations of a Common European Adder (Vipera berus) Bite in Romania.

Authors:  Gabriela Viorela Nițescu; Coriolan Emil Ulmeanu; Maria-Dorina Crăciun; Alina Maria Ciucă; Alexandru Ulici; Ioan Ghira; Davide Lonati
Journal:  Toxins (Basel)       Date:  2022-07-18       Impact factor: 5.075

5.  Acute Exposure to European Viper Bite in Children: Advocating for a Pediatric Approach.

Authors:  Marco Marano; Mara Pisani; Giorgio Zampini; Giuseppe Pontrelli; Marco Roversi
Journal:  Toxins (Basel)       Date:  2021-05-02       Impact factor: 4.546

Review 6.  Snakebite management in Iran: Devising a protocol.

Authors:  Seyed Mostafa Monzavi; Bita Dadpour; Reza Afshari
Journal:  J Res Med Sci       Date:  2014-02       Impact factor: 1.852

7.  A Single Dose of Viperfav(TM) May Be Inadequate for Vipera ammodytes Snake Bite: A Case Report and Pharmacokinetic Evaluation.

Authors:  Tihana Kurtović; Miran Brvar; Damjan Grenc; Maja Lang Balija; Igor Križaj; Beata Halassy
Journal:  Toxins (Basel)       Date:  2016-08-19       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.